Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SARS-CoV-2 variants and vaccination.

Literature DB >> 35284912

SARS-CoV-2 variants and vaccination.

Yang Liu¹, Jianying Liu¹, Pei-Yong Shi^2,3,4,5,6.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused global destruction since its emergence in late 2019. Over the past two years, the virus has continuously evolved in human host, leading to emergence of variants with changed viral transmission, disease severity, and evasion of immunity. Although vaccines have been developed for the coronavirus disease 2019 (COVID-19) at an unprecedently pace, the variants have constantly posed threats to the effectiveness of the approved vaccines. In this short communication, we review the key variants and discuss their implications in viral replication, transmission, and immune evasion.

Entities: Chemical

Keywords: COVID-19; SARS-CoV-2 variants; neutralization; spike mutations; vaccine

Year: 2022 PMID： 35284912 PMCID： PMC8909890 DOI： 10.15212/zoonoses-2022-0001

Source DB: PubMed Journal: Zoonoses (Burlingt)

40 in total

1. Emergence of a Novel SARS-CoV-2 Variant in Southern California.

Authors: Wenjuan Zhang; Brian D Davis; Stephanie S Chen; Jorge M Sincuir Martinez; Jasmine T Plummer; Eric Vail
Journal: JAMA Date: 2021-04-06 Impact factor: 56.272

2. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.

Authors: Yang Liu; Jianying Liu; Kenneth S Plante; Jessica A Plante; Xuping Xie; Xianwen Zhang; Zhiqiang Ku; Zhiqiang An; Dionna Scharton; Craig Schindewolf; Steven G Widen; Vineet D Menachery; Pei-Yong Shi; Scott C Weaver
Journal: Nature Date: 2021-11-24 Impact factor: 49.962

3. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

Authors: Elisabetta Cameroni; John E Bowen; Laura E Rosen; Christian Saliba; Samantha K Zepeda; Katja Culap; Dora Pinto; Laura A VanBlargan; Anna De Marco; Julia di Iulio; Fabrizia Zatta; Hannah Kaiser; Julia Noack; Nisar Farhat; Nadine Czudnochowski; Colin Havenar-Daughton; Kaitlin R Sprouse; Josh R Dillen; Abigail E Powell; Alex Chen; Cyrus Maher; Li Yin; David Sun; Leah Soriaga; Jessica Bassi; Chiara Silacci-Fregni; Claes Gustafsson; Nicholas M Franko; Jenni Logue; Najeeha Talat Iqbal; Ignacio Mazzitelli; Jorge Geffner; Renata Grifantini; Helen Chu; Andrea Gori; Agostino Riva; Olivier Giannini; Alessandro Ceschi; Paolo Ferrari; Pietro E Cippà; Alessandra Franzetti-Pellanda; Christian Garzoni; Peter J Halfmann; Yoshihiro Kawaoka; Christy Hebner; Lisa A Purcell; Luca Piccoli; Matteo Samuele Pizzuto; Alexandra C Walls; Michael S Diamond; Amalio Telenti; Herbert W Virgin; Antonio Lanzavecchia; Gyorgy Snell; David Veesler; Davide Corti
Journal: Nature Date: 2021-12-23 Impact factor: 69.504

4. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.

Authors: Jianying Liu; Yang Liu; Hongjie Xia; Jing Zou; Scott C Weaver; Kena A Swanson; Hui Cai; Mark Cutler; David Cooper; Alexander Muik; Kathrin U Jansen; Ugur Sahin; Xuping Xie; Philip R Dormitzer; Pei-Yong Shi
Journal: Nature Date: 2021-06-10 Impact factor: 49.962

5. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.

Authors: Matthew McCallum; Jessica Bassi; Anna De Marco; Alex Chen; Alexandra C Walls; Julia Di Iulio; M Alejandra Tortorici; Mary-Jane Navarro; Chiara Silacci-Fregni; Christian Saliba; Kaitlin R Sprouse; Maria Agostini; Dora Pinto; Katja Culap; Siro Bianchi; Stefano Jaconi; Elisabetta Cameroni; John E Bowen; Sasha W Tilles; Matteo Samuele Pizzuto; Sonja Bernasconi Guastalla; Giovanni Bona; Alessandra Franzetti Pellanda; Christian Garzoni; Wesley C Van Voorhis; Laura E Rosen; Gyorgy Snell; Amalio Telenti; Herbert W Virgin; Luca Piccoli; Davide Corti; David Veesler
Journal: Science Date: 2021-07-01 Impact factor: 47.728

6. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.

Authors: Jing Zou; Xuping Xie; Camila R Fontes-Garfias; Kena A Swanson; Isis Kanevsky; Kristin Tompkins; Mark Cutler; David Cooper; Philip R Dormitzer; Pei-Yong Shi
Journal: NPJ Vaccines Date: 2021-03-25 Impact factor: 7.344

7. Neutralizing Activity of BNT162b2-Elicited Serum.

Authors: Yang Liu; Jianying Liu; Hongjie Xia; Xianwen Zhang; Camila R Fontes-Garfias; Kena A Swanson; Hui Cai; Ritu Sarkar; Wei Chen; Mark Cutler; David Cooper; Scott C Weaver; Alexander Muik; Ugur Sahin; Kathrin U Jansen; Xuping Xie; Philip R Dormitzer; Pei-Yong Shi
Journal: N Engl J Med Date: 2021-03-08 Impact factor: 91.245

Review 8. COVID-19 Vaccine: A comprehensive status report.

Authors: Simran Preet Kaur; Vandana Gupta
Journal: Virus Res Date: 2020-08-13 Impact factor: 3.303

9. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors: Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal: Cell Date: 2020-07-03 Impact factor: 66.850

6 in total

1. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.

Authors: Lunzhi Yuan; Huachen Zhu; Peiwen Chen; Ming Zhou; Jian Ma; Xuan Liu; Kun Wu; Rirong Chen; Qiwei Liu; Huan Yu; Lifeng Li; Jia Wang; Yali Zhang; Shengxiang Ge; Quan Yuan; Qiyi Tang; Tong Cheng; Yi Guan; Ningshao Xia
Journal: Cell Mol Immunol Date: 2022-10-18 Impact factor: 22.096

SARS-CoV-2 variants and vaccination.

1. Emergence of a Novel SARS-CoV-2 Variant in Southern California.

2. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.

3. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

4. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants.

5. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.

6. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.

7. Neutralizing Activity of BNT162b2-Elicited Serum.

Review 8. COVID-19 Vaccine: A comprehensive status report.

9. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

1. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.

Review 2. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.

3. Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant.

4. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.

5. Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections.

6. Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes.